<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three recipients of kidney allotransplants developed dysmyeloproliferative syndromes which were fully reversible after switching from <z:chebi fb="2" ids="2948">azathioprine</z:chebi> to <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> for immunosuppression </plain></SENT>
<SENT sid="1" pm="."><plain>Similar bone marrow changes described in the literature progressed to <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Whether the abnormalities observed in our patients could be early stages of the disease described in the literature and whether a fatal development can be prevented by changing the immunosuppressive therapy remains to be elucidated </plain></SENT>
</text></document>